A carregar...

Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureter.

Fourteen patients with previously treated, locally advanced/metastatic transitional cell carcinoma (TCC) of the bladder or ureter received paclitaxel at a dose of 200 mg m-2 administered as a 3-h infusion every 21 days. The activity of paclitaxel in this group of patients was modest. The response ra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Papamichael, D., Gallagher, C. J., Oliver, R. T., Johnson, P. W., Waxman, J.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group|1 1997
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2063294/
https://ncbi.nlm.nih.gov/pubmed/9052419
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!